BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37298386)

  • 1. The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies.
    Zabłocki K; Górecki DC
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The P2X7 purinoceptor in pathogenesis and treatment of dystrophino- and sarcoglycanopathies.
    Gόrecki DC; Rumney RMH
    Curr Opin Pharmacol; 2023 Apr; 69():102357. PubMed ID: 36842388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X7 purinoceptor as a therapeutic target in muscular dystrophies.
    Górecki DC
    Curr Opin Pharmacol; 2019 Aug; 47():40-45. PubMed ID: 30901735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Adenosine Triphosphate Release and Impairment of P2Y2-Mediated Signaling in Sarcoglycanopathies.
    Benzi A; Baratto S; Astigiano C; Sturla L; Panicucci C; Mamchaoui K; Raffaghello L; Bruzzone S; Gazzerro E; Bruno C
    Lab Invest; 2023 Mar; 103(3):100037. PubMed ID: 36925196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
    Sinadinos A; Young CN; Al-Khalidi R; Teti A; Kalinski P; Mohamad S; Floriot L; Henry T; Tozzi G; Jiang T; Wurtz O; Lefebvre A; Shugay M; Tong J; Vaudry D; Arkle S; doRego JC; Górecki DC
    PLoS Med; 2015 Oct; 12(10):e1001888. PubMed ID: 26461208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
    Al-Khalidi R; Panicucci C; Cox P; Chira N; Róg J; Young CNJ; McGeehan RE; Ambati K; Ambati J; Zabłocki K; Gazzerro E; Arkle S; Bruno C; Górecki DC
    Acta Neuropathol Commun; 2018 Apr; 6(1):27. PubMed ID: 29642926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment.
    Young CN; Brutkowski W; Lien CF; Arkle S; Lochmüller H; Zabłocki K; Górecki DC
    J Cell Mol Med; 2012 May; 16(5):1026-37. PubMed ID: 21794079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90.
    Young CN; Sinadinos A; Lefebvre A; Chan P; Arkle S; Vaudry D; Gorecki DC
    Autophagy; 2015; 11(1):113-30. PubMed ID: 25700737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Danger Signal Extracellular ATP Is Involved in the Immunomediated Damage of α-Sarcoglycan-Deficient Muscular Dystrophy.
    Gazzerro E; Baratto S; Assereto S; Baldassari S; Panicucci C; Raffaghello L; Scudieri P; De Battista D; Fiorillo C; Volpi S; Chaabane L; Malnati M; Messina G; Bruzzone S; Traggiai E; Grassi F; Minetti C; Bruno C
    Am J Pathol; 2019 Feb; 189(2):354-369. PubMed ID: 30448410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. eATP/P2X7R Axis: An Orchestrated Pathway Triggering Inflammasome Activation in Muscle Diseases.
    Panicucci C; Raffaghello L; Bruzzone S; Baratto S; Principi E; Minetti C; Gazzerro E; Bruno C
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of P2RX7 ablation on the morphological, mechanical and tissue properties of bones in a murine model of duchenne muscular dystrophy.
    Mohamad NS; Sinadinos A; Górecki DC; Zioupos P; Tong J
    J Biomech; 2016 Oct; 49(14):3444-3451. PubMed ID: 27663621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystrophic mdx mouse myoblasts exhibit elevated ATP/UTP-evoked metabotropic purinergic responses and alterations in calcium signalling.
    Róg J; Oksiejuk A; Gosselin MRF; Brutkowski W; Dymkowska D; Nowak N; Robson S; Górecki DC; Zabłocki K
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1138-1151. PubMed ID: 30684640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of the sarcolemma-enriched fraction from dystrophic mdx-4cv skeletal muscle.
    Murphy S; Zweyer M; Henry M; Meleady P; Mundegar RR; Swandulla D; Ohlendieck K
    J Proteomics; 2019 Jan; 191():212-227. PubMed ID: 29408692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X Axis.
    Gazzerro E; Baldassari S; Assereto S; Fruscione F; Pistorio A; Panicucci C; Volpi S; Perruzza L; Fiorillo C; Minetti C; Traggiai E; Grassi F; Bruno C
    Am J Pathol; 2015 Dec; 185(12):3349-60. PubMed ID: 26465071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice.
    Porter JD; Khanna S; Kaminski HJ; Rao JS; Merriam AP; Richmonds CR; Leahy P; Li J; Guo W; Andrade FH
    Hum Mol Genet; 2002 Feb; 11(3):263-72. PubMed ID: 11823445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.